Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP802979.RAm-I2-fTAjEnfdcAa7-LpNPMiIVJHgX1rqMq5l1BqtOk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP802979.RAm-I2-fTAjEnfdcAa7-LpNPMiIVJHgX1rqMq5l1BqtOk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP802979.RAm-I2-fTAjEnfdcAa7-LpNPMiIVJHgX1rqMq5l1BqtOk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP802979.RAm-I2-fTAjEnfdcAa7-LpNPMiIVJHgX1rqMq5l1BqtOk130_provenance.
- NP802979.RAm-I2-fTAjEnfdcAa7-LpNPMiIVJHgX1rqMq5l1BqtOk130_assertion description "[MET, a receptor tyrosine kinase for hepatocyte growth factor, is associated with tumor progression and acquired resistance to epidermal growth factor tyrosine kinase inhibitors (EGFR-TKI).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802979.RAm-I2-fTAjEnfdcAa7-LpNPMiIVJHgX1rqMq5l1BqtOk130_provenance.
- NP802979.RAm-I2-fTAjEnfdcAa7-LpNPMiIVJHgX1rqMq5l1BqtOk130_assertion evidence source_evidence_literature NP802979.RAm-I2-fTAjEnfdcAa7-LpNPMiIVJHgX1rqMq5l1BqtOk130_provenance.
- NP802979.RAm-I2-fTAjEnfdcAa7-LpNPMiIVJHgX1rqMq5l1BqtOk130_assertion SIO_000772 21733594 NP802979.RAm-I2-fTAjEnfdcAa7-LpNPMiIVJHgX1rqMq5l1BqtOk130_provenance.
- NP802979.RAm-I2-fTAjEnfdcAa7-LpNPMiIVJHgX1rqMq5l1BqtOk130_assertion wasDerivedFrom befree-20150227 NP802979.RAm-I2-fTAjEnfdcAa7-LpNPMiIVJHgX1rqMq5l1BqtOk130_provenance.
- NP802979.RAm-I2-fTAjEnfdcAa7-LpNPMiIVJHgX1rqMq5l1BqtOk130_assertion wasGeneratedBy ECO_0000203 NP802979.RAm-I2-fTAjEnfdcAa7-LpNPMiIVJHgX1rqMq5l1BqtOk130_provenance.
- befree-20150227 importedOn "2015-02-27" NP802979.RAm-I2-fTAjEnfdcAa7-LpNPMiIVJHgX1rqMq5l1BqtOk130_provenance.